FINISHED DOSAGE FORMULATIONS
Drug : RECTIV
Dosage Form : OINTMENT; INTRA-ANAL
Application Number : 21359
Country : US
Patented : No
Drug : CLOBETASOL PROPIONATE
Dosage Form : OINTMENT; TOPICAL
Application Number : 211800
Country : US
Patented : No
Drug : CLOBETASOL PROPIONATE
Dosage Form : OINTMENT; TOPICAL
Application Number : 75057
Country : US
Patented : No
Drug : FLUTICASONE PROPIONATE
Dosage Form : OINTMENT; TOPICAL
Application Number : 76300
Country : US
Patented : No
Drug : HALOBETASOL PROPIONATE
Dosage Form : OINTMENT; TOPICAL
Application Number : 77721
Country : US
Patented : No
Drug : CLOBETASOL PROPIONATE
Dosage Form : OINTMENT; TOPICAL
Application Number : 74089
Country : US
Patented : No
Drug : HALOBETASOL PROPIONATE
Dosage Form : OINTMENT; TOPICAL
Application Number : 209978
Country : US
Patented : No
Drug : HALOBETASOL PROPIONATE
Dosage Form : OINTMENT; TOPICAL
Application Number : 76903
Country : US
Patented : No
Drug : CLOBETASOL PROPIONATE
Dosage Form : CREAM; TOPICAL
Application Number : 74392
Country : US
Patented : No
Drug : CLOBETASOL PROPIONATE
Dosage Form : OINTMENT; TOPICAL
Application Number : 74407
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Oral
Category : Surfactant & Foaming Agents
Application : Surfactant & Foaming Agents
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, FDA...
Technical Specs : Not Available
Ingredient(s) : sorbitan sesquioleate
MARKET PLACE